Affiliate disclosure: Care Path Compare may receive compensation if you use the Wellmedr link and start a program, at no extra cost to you. We do not have an active commercial affiliate partnership with Hims. Compensation does not dictate our editorial comparisons, pricing calculations, or clinical recommendations.
Hims vs. Wellmedr: Quick comparison matrix
The table below contrasts the medication options, commitment tiers, pharmacy sourcing, and out-of-pocket costs of Hims and Wellmedr.
| Comparison Factor | Hims & Hers | Wellmedr |
|---|---|---|
| Starting Compounded Semaglutide | $199/mo (requires $2,388 upfront annual commitment) | $49 promotional month 1 (ongoing $229/mo flat) |
| Month-to-Month Semaglutide Cost | $399/month (no annual commitment) | $229/month flat (all-inclusive) |
| Compounded Tirzepatide Available? | No (Hims does not offer compounded tirzepatide) | Yes ($89 promo month 1; $329/mo ongoing flat) |
| Upfront Outlay on Day 1 (Semaglutide) | $1,494 (6-mo plan) or $2,388 (annual plan) | $49 (promotional entry plan) |
| Separate Membership Fee | $0 (bundled into subscription) | $0 (bundled into medication plan) |
| Dose Escalation Price Increases | Flat rate across semaglutide dose strengths | Flat rate across dose strengths |
| Physician Consultation Model | Asynchronous medical questionnaire review | Asynchronous medical questionnaire review |
| Diagnostic Lab Work Required? | Not routinely required for eligible candidates | Rarely required for healthy adults |
| Compounding Pharmacy Sourcing | BPI Labs (FDA 503B outsourcing facility) + 503A partners | Logos RX, Emerald Compounding, Center City Pharmacy (503A) |
| Oral Weight Loss Medication Options | Yes (custom oral kits: bupropion, naltrexone, metformin) | Focuses exclusively on injectable GLP-1s |
| Digital App & Tracking | Proprietary iOS/Android mobile app with habit tracking | Web-based patient portal for orders and messaging |
| Refill & Billing Cadence | Multi-month bulk billing (3-, 6-, or 12-month renewal cycles) | ~21-day order fulfillment cadence |
| Cancellation Policy | Must cancel at least 48 hours prior to renewal date | Must cancel before order reaches fulfillment processing |
| State Availability | Available in most U.S. states | 50 U.S. states |
Commercial prices, subscription terms, and pharmacy networks were verified October 24, 2026, and are subject to change.
4 core differences between Hims and Wellmedr
While both platforms provide virtual clinician access for compounded GLP-1 weight loss, four fundamental differences determine which provider is best suited for your medical needs and budget.
1. Tirzepatide availability: The decisive clinical divide
The most crucial medical distinction between the two services is drug selection:
- Hims does not offer compounded tirzepatide. Hims limits its injectable GLP-1 catalog exclusively to compounded semaglutide (the active ingredient in Ozempic and Wegovy). For patients seeking dual GIP/GLP-1 receptor agonism—which demonstrated superior clinical weight reduction in the SURMOUNT-1 clinical trial (20.9% average body weight loss vs. 14.9% for semaglutide in STEP-1)—Hims is not an option.
- Wellmedr provides both compounded semaglutide and compounded tirzepatide. Wellmedr allows eligible patients to choose either medication or transition between them under clinical supervision if they plateau on semaglutide or experience gastrointestinal intolerance.
2. The $199 headline trap: Annual prepayment vs. low upfront entry
How each platform structures its pricing represents the biggest financial trap in virtual weight loss:
- Hims locks you into multi-month prepaid agreements. Hims heavily markets its “$199/month” semaglutide rate across television and social media. However, that $199 price is only available if you pay $2,388 upfront for an entire year. If you select their 6-month plan, the price rises to $249/month ($1,494 billed immediately). If you select their 3-month plan, it is $299/month ($897 billed immediately). If you insist on standard month-to-month billing, Hims charges $399 per month. If you experience intolerable nausea in month one, your thousands in prepaid fees are non-refundable.
- Wellmedr offers an accessible month-to-month pathway. Wellmedr provides promotional introductory rates of $49 for semaglutide and $89 for tirzepatide for your first vial. Afterward, pricing transitions to a flat monthly rate of $229 for semaglutide and $329 for tirzepatide without demanding thousands of dollars in advance.
3. Pharmacy fulfillment: 503B outsourcing facilities vs. 503A compounding
Both companies utilize licensed compounding facilities, but their operational classifications differ:
- Hims utilizes FDA-registered 503B outsourcing facilities. Hims sources compounded semaglutide primarily through BPI Labs, an FDA-registered 503B outsourcing facility, alongside partner 503A pharmacies. 503B facilities operate under Current Good Manufacturing Practice (cGMP) regulations similar to commercial pharmaceutical manufacturers and undergo routine FDA inspections.
- Wellmedr partners with state-licensed 503A compounding pharmacies. Wellmedr fulfills prescriptions through established state-licensed 503A pharmacies including Logos RX, Emerald Compounding Pharmacy, and Center City Pharmacy. 503A pharmacies formulate medications on an individual patient-specific prescription basis under state board of pharmacy oversight.
Compounded formulations from neither provider are FDA-approved finished drugs. They carry important considerations regarding potency, sterility, and individual clinical suitability.
4. Billing schedules and renewal lock-in
Managing refills and renewals requires understanding each provider’s subscription mechanics:
- Hims renews in large multi-month blocks. If you sign up for a 3-, 6-, or 12-month plan with Hims, your subscription is set to automatically renew for the same multi-month period at full retail price when the term expires. You must submit a cancellation request through your Hims account settings at least 48 hours before the renewal date; otherwise, your credit card will be charged hundreds or thousands of dollars for the next term.
- Wellmedr operates on a ~21-day order processing window. Wellmedr reviews refills approximately every 21 days to ensure timely pharmacy formulation and cold-chain shipping. Patients can pause or adjust their dosage between orders without being locked into multi-month prepaid contracts.
Real-world cost comparison: Outlay scenarios across 6 and 12 months
To evaluate true affordability, look at the actual cash required at checkout across common treatment timelines.
Scenario A: 6 months of compounded semaglutide
| Expense Category | Hims (6-Month Prepaid Commitment) | Wellmedr (Month-to-Month Flexibility) |
|---|---|---|
| Day 1 Checkout Charge | $1,494 upfront ($249/mo × 6) | $49 (introductory promo) |
| Ongoing Monthly Outlay | $0 (prepaid) | $229/month flat (months 2–6) |
| Total 6-Month Investment | $1,494 total | $1,194 total |
| Total Savings with Wellmedr | — | Save $300 + zero upfront lock-in |
Verdict: Wellmedr is $300 cheaper over 6 months while requiring only $49 on day one, compared to Hims demanding nearly $1,500 before your first dose arrives. If you opted for Hims’ month-to-month option ($399/mo), Wellmedr saves you $1,200.
Scenario B: 12 months of compounded semaglutide
| Expense Category | Hims (12-Month Prepaid Commitment) | Wellmedr (Ongoing Monthly Care) |
|---|---|---|
| Day 1 Checkout Charge | $2,388 upfront ($199/mo × 12) | $49 (introductory promo) |
| Ongoing Monthly Outlay | $0 (prepaid) | $229/month flat (months 2–12) |
| Total 12-Month Investment | $2,388 total | $2,568 total |
| Price Difference | Hims saves $180 over 1 full year | Wellmedr requires $0 annual contract |
Verdict: If you are 100% certain you can tolerate semaglutide for a full year without side effects, discontinuation, or plateaus, Hims is approximately $15/month cheaper ($180 over 12 months). However, you must surrender $2,388 upfront on day one. If you stop treatment early with Hims, you lose the unused balance.
Who is Wellmedr best for?
Wellmedr is the recommended choice for patients who:
- Want compounded tirzepatide, which Hims does not offer.
- Refuse to pay $1,500 to $2,400 upfront on day one before knowing how their body tolerates GLP-1 side effects.
- Prefer the lowest financial entry barrier with introductory rates of $49 for semaglutide and $89 for tirzepatide.
- Want transparent, flat month-to-month pricing ($229/mo for semaglutide; $329/mo for tirzepatide) without annual contract penalties.
- Prefer a straightforward clinical intake and web portal without mandatory multi-month auto-renewal blocks.
Who is Hims best for?
Hims is the preferred choice for patients who:
- Are completely comfortable prepaying $2,388 upfront to lock in a $199/month effective rate for a full year.
- Only want semaglutide and have no interest in dual incretin medications like tirzepatide.
- Value the convenience and polish of a dedicated mobile companion app with built-in daily habit tracking and hydration logging.
- Prefer sourcing compounded medications formulated through FDA-registered 503B outsourcing facilities (BPI Labs).
- Want the option to explore non-GLP-1 oral weight-loss kits (combinations of bupropion, naltrexone, and metformin).
Key questions to ask before paying
Before entering your payment details on either platform, verify these crucial points:
- How much will be charged to my credit card today? Confirm whether you are paying for one month or committing to a 3-, 6-, or 12-month upfront charge.
- Does the provider offer tirzepatide if I don’t respond to semaglutide? Confirm whether an alternative GLP-1 molecule is available if you experience inadequate weight loss.
- What happens if I experience severe nausea or side effects? Can you cancel and receive a prorated refund for unfulfilled months, or are all prepaid funds forfeited?
- When do I need to cancel to prevent an automatic subscription renewal? Note the required notice deadline (e.g., 48 hours before renewal with Hims).
- Which compounding pharmacy prepares and ships the medication? Verify whether your prescription is formulated by a 503A compounding pharmacy or a 503B outsourcing facility.